poisar

Stocks · News reference

BlossomHill Therapeutics Announces Upcoming Poster Presentation for BH-30236 at ASH Annual Meeting

Fiscal.ai

BlossomHill Therapeutics will present preclinical and clinical data for its CLK inhibitor, BH-30236, at the 68th American Society of Hematology Annual Meeting in December 2026.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading